-
03-26
2022Dacomitinib (PF299804, PF299), CAS:1110813-31-4 大包装
Name：Dacomitinib (PF299804, PF299)Formulation：in 10mM DMSOTarget：EGFRPathway：Protein Tyrosine KinaseInformation：Dacomitinib (PF299804, PF299) is a potent, -
03-26
2022Fedratinib (SAR302503, TG101348), CAS:936091-26-8 工艺放大
Name：Fedratinib (SAR302503, TG101348)Formulation：in 10mM DMSOTarget：JAKPathway：JAK/STATInformation：Fedratinib (SAR302503, TG101348) is a selective inhibito -
03-26
2022Niraparib (MK-4827), CAS:1038915-60-4 线路优化
Name：Niraparib (MK-4827)Formulation：in 10mM DMSOTarget：PARPPathway：DNA DamageInformation：Niraparib (MK-4827) is a selective inhibitor of PARP1/2 with IC50 -
03-26
2022Canagliflozin, CAS:842133-18-0 化合物优化
Name：CanagliflozinFormulation：in 10mM DMSOTarget：SGLTPathway：GPCR & G ProteinInformation：Canagliflozin is a highly potent and selective SGLT2 inhibitor for -
03-26
2022Alectinib (CH5424802), CAS:1256580-46-7 公斤级
Name：Alectinib (CH5424802)Formulation：in 10mM DMSOTarget：ALKPathway：Protein Tyrosine KinaseInformation：Alectinib (CH5424802) is a potent ALK inhibitor with -
03-26
2022Tofacitinib (CP-690550,Tasocitinib), CAS:477600-75-2 小试供应
Name：Tofacitinib (CP-690550,Tasocitinib)Formulation：in 10mM DMSOTarget：JAKPathway：JAK/STATInformation：Tofacitinib (CP-690550,Tasocitinib) is a novel inhibi -
03-26
2022Istradefylline, CAS:155270-99-8 中试供应
Name：IstradefyllineFormulation：in 10mM DMSOTarget：Adenosine ReceptorPathway：GPCR & G ProteinInformation：Istradefylline is a selective adenosine A2A recepto -
03-26
2022Torcetrapib, CAS:262352-17-0 路线研究
Name：TorcetrapibFormulation：in 10mM DMSOTarget：CETPPathway：MetabolismInformation：Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and red -
03-26
2022Lonafarnib, CAS:193275-84-2 化合物合成
Name：LonafarnibFormulation：in 10mM DMSOTarget：TransferasePathway：MetabolismInformation：Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-r -
03-26
2022Dabrafenib (GSK2118436), CAS:1195765-45-7 工艺优化
Name：Dabrafenib (GSK2118436)Formulation：in 10mM DMSOTarget：RafPathway：MAPKInformation：Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with
